Última hora

RUAbelardo de la Espriella leads Colombia presidential election runoff GLOBALWyndham Clark Secures Second US Open Title Amidst Fan Hostility GLOBALActress Warns of Complex Reality of Images and Online Abuse Beyond Nudity INTLTrump Calls for Military Intervention in Chicago Amid Weekend Shootings RUIran Withdraws from Talks in Switzerland After Trump Statements CNUS-Iran Talks Continue Overnight on Middle East War UKUK Taxpayers Want Higher Levies on Big Tech, Survey Finds INTLUK to Use AI to Help Climate-Vulnerable Nations Prepare for Extreme Weather AUQueensland Watch Houses Overcrowded Despite Internal Review GLOBALIndian students reconsider overseas education amid currency woes and job fears RUAbelardo de la Espriella leads Colombia presidential election runoff GLOBALWyndham Clark Secures Second US Open Title Amidst Fan Hostility GLOBALActress Warns of Complex Reality of Images and Online Abuse Beyond Nudity INTLTrump Calls for Military Intervention in Chicago Amid Weekend Shootings RUIran Withdraws from Talks in Switzerland After Trump Statements CNUS-Iran Talks Continue Overnight on Middle East War UKUK Taxpayers Want Higher Levies on Big Tech, Survey Finds INTLUK to Use AI to Help Climate-Vulnerable Nations Prepare for Extreme Weather AUQueensland Watch Houses Overcrowded Despite Internal Review GLOBALIndian students reconsider overseas education amid currency woes and job fears

Iniciar sesión

small molecule drugs

Estable1 noticias1 fuentesÚltima actualización: 25.05.2026

Temas relacionadoscancer immunotherapy NK cells McGill University acute myeloid leukemia kidney cancer glioblastoma triple-negative breast cancer CAR-T therapy

Últimas noticias

New Study: Small Molecule Drugs Can Temporarily Boost NK Cells for Cancer Attack

Salud·25.05.2026Resumen IA

New Study: Small Molecule Drugs Can Temporarily Boost NK Cells for Cancer Attack

Canadian researchers discovered small molecule drugs can temporarily enhance Natural Killer (NK) cells' ability to attack aggressive cancer cells without genetic modification, potentially offering a safer, more affordable cancer immunotherapy.